Federal investigators raised concerns about how Medicare Advantage plans handle requests for post-hospital recovery care, finding that many denials were later overturned on appeal. Two reports from th
Humana (NYSE:HUM) agreed to sell its minority stake in Gentiva for approximately US$900 million, exiting equity ownership in home health, palliative, and hospice care. The insurer was also selected as
HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.
The insurer is offloading its interest in the massive end-of-life care provider to an undisclosed group of investors, amid widespread concern about private investors’ activity in healthcare.
Economist Justin Wolfers dropped a number on the Prof G Markets podcast that should reorganize how you think about the 2026 economy. Since Trump took office, healthcare and social services has added r
As Centene has notably outperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
As tech stocks have pulled back lately, weighing on the major indexes, healthcare stocks are surging ahead.
The state said it intends to divvy out new contracts, which represent tens of billions of dollars in revenue for each awardee, to six insurers. Winners are mostly incumbents, except for Humana.
View interactive chart, options flow, and AI analysis for HUM on Zorveq Finance.
Open HUM Chart & Analysis →